Flutter Shares Drop After Mixed Q2 Results, Guidance Cut and CEO Transition
Flutter reported mixed Q2 numbers, lowered 2026 outlook, and announced CEO Peter Jackson’s exit.
Already have an account? Sign in.
Flutter reported mixed Q2 numbers, lowered 2026 outlook, and announced CEO Peter Jackson’s exit.
Investors sold CGNX on valuation and cash spend.
FDA clears TriSalus’ TriNav Advance, designed to push more treatment into liver tumors and less into healthy tissue via a SmartValve.
The company says real-time quantum error decoding can run in the background on commodity hardware instead of custom FPGA, GPU, or ASIC farms.